LeserbriefRandomisierte kontrollierte Studie
Letter to the Editor Re: A Randomized Trial of Rifaximin vs Low FODMAP Diet
Clinical Gastroenterology and Hepatology · 2026-09
DOI: 10.1016/j.cgh.2026.08.035 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-09. Verfasst von Robert Burke und 2 weiteren Autor:innen. Beteiligte Einrichtung: FoodMarble Digestive Health, Dublin, Ireland. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- FoodMarble Digestive Health, Dublin, Ireland.
Zitieren
APA
Burke, R., Shortt, C., & Shortt, A. (2026). Letter to the Editor Re: A Randomized Trial of Rifaximin vs Low FODMAP Diet. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2026.08.035
Vancouver
Burke R, Shortt C, Shortt A. Letter to the Editor Re: A Randomized Trial of Rifaximin vs Low FODMAP Diet. Clinical Gastroenterology and Hepatology. 2026. doi:10.1016/j.cgh.2026.08.035
BibTeX
@article{Burke2026,
author = {Burke, Robert and Shortt, Claire and Shortt, Aonghus},
title = {Letter to the Editor Re: A Randomized Trial of Rifaximin vs Low FODMAP Diet},
journal = {Clinical Gastroenterology and Hepatology},
year = {2026},
doi = {10.1016/j.cgh.2026.08.035}
}
EUVIMED